138 related articles for article (PubMed ID: 23985994)
1. SLC24A5 mutations are associated with non-syndromic oculocutaneous albinism.
Morice-Picard F; Lasseaux E; François S; Simon D; Rooryck C; Bieth E; Colin E; Bonneau D; Journel H; Walraedt S; Leroy BP; Meire F; Lacombe D; Arveiler B
J Invest Dermatol; 2014 Feb; 134(2):568-571. PubMed ID: 23985994
[No Abstract] [Full Text] [Related]
2. Identification of two Chinese oculocutaneous albinism type 6 patients and mutation updates of the SLC24A5 gene.
Zhang Y; Zhang Y; Liu T; Bai D; Yang X; Li W; Wei A
J Dermatol; 2019 Nov; 46(11):1027-1030. PubMed ID: 31486119
[TBL] [Abstract][Full Text] [Related]
3. Exome sequencing identifies SLC24A5 as a candidate gene for nonsyndromic oculocutaneous albinism.
Wei AH; Zang DJ; Zhang Z; Liu XZ; He X; Yang L; Wang Y; Zhou ZY; Zhang MR; Dai LL; Yang XM; Li W
J Invest Dermatol; 2013 Jul; 133(7):1834-40. PubMed ID: 23364476
[TBL] [Abstract][Full Text] [Related]
4. Identification of a homozygous mutation of SLC24A5 (OCA6) in two patients with oculocutaneous albinism from French Guiana.
Bertolotti A; Lasseaux E; Plaisant C; Trimouille A; Morice-Picard F; Rooryck C; Lacombe D; Couppie P; Arveiler B
Pigment Cell Melanoma Res; 2016 Jan; 29(1):104-6. PubMed ID: 26491832
[No Abstract] [Full Text] [Related]
5. Birth prevalence and mutation spectrum in danish patients with autosomal recessive albinism.
Grønskov K; Ek J; Sand A; Scheller R; Bygum A; Brixen K; Brondum-Nielsen K; Rosenberg T
Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1058-64. PubMed ID: 19060277
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of SLC24A5 variants and evaluation of Nitisinone treatment efficacy in a zebrafish model of OCA6.
Yousaf S; Sethna S; Chaudhary MA; Shaikh RS; Riazuddin S; Ahmed ZM
Pigment Cell Melanoma Res; 2020 Jul; 33(4):556-565. PubMed ID: 32274888
[TBL] [Abstract][Full Text] [Related]
7. A Functional Study of Mutations in K+-dependent Na+-Ca2+ Exchangers Associated with Amelogenesis Imperfecta and Non-syndromic Oculocutaneous Albinism.
Jalloul AH; Rogasevskaia TP; Szerencsei RT; Schnetkamp PP
J Biol Chem; 2016 Jun; 291(25):13113-23. PubMed ID: 27129268
[TBL] [Abstract][Full Text] [Related]
8.
Kumar R; Bansal A; Shukla R; Raj Singh T; Wasudeo Ramteke P; Singh S; Gautam B
J Biomol Struct Dyn; 2019 Aug; 37(13):3513-3523. PubMed ID: 30204049
[TBL] [Abstract][Full Text] [Related]
9. SLC45A2 mutation frequency in Oculocutaneous Albinism Italian patients doesn't differ from other European studies.
Mauri L; Barone L; Al Oum M; Del Longo A; Piozzi E; Manfredini E; Stanzial F; Benedicenti F; Penco S; Patrosso MC
Gene; 2014 Jan; 533(1):398-402. PubMed ID: 24096233
[TBL] [Abstract][Full Text] [Related]
10. [Oculocutaneous albinism 1B associated with a new mutation in the TYR gene].
Vidal-Ríos P; Fernández-Seara MJ; Cortés E; Hurtado L; Couce ML
An Pediatr (Barc); 2013 May; 78(5):339-40. PubMed ID: 23085315
[No Abstract] [Full Text] [Related]
11. Spectrum of candidate gene mutations associated with Indian familial oculocutaneous and ocular albinism.
Renugadevi K; Sil AK; Perumalsamy V; Sundaresan P
Mol Vis; 2010 Aug; 16():1514-24. PubMed ID: 20806075
[TBL] [Abstract][Full Text] [Related]
12. Oculocutaneous albinism.
Biswas S; Lloyd IC
Arch Dis Child; 1999 Jun; 80(6):565-9. PubMed ID: 10332009
[No Abstract] [Full Text] [Related]
13. Molecular basis of oculocutaneous albinism.
Oetting WS; King RA
J Invest Dermatol; 1994 Nov; 103(5 Suppl):131S-136S. PubMed ID: 7963676
[TBL] [Abstract][Full Text] [Related]
14. Oculocutaneous albinism (OCA) in Colombia: first molecular screening of the TYR and OCA2 genes in South America.
Urtatiz O; Sanabria D; Lattig MC
J Dermatol Sci; 2014 Dec; 76(3):260-2. PubMed ID: 25455140
[No Abstract] [Full Text] [Related]
15. Hermansky-Pudlak syndrome and oculocutaneous albinism in Chinese children with pigmentation defects and easy bruising.
Power B; Ferreira CR; Chen D; Zein WM; O'Brien KJ; Introne WJ; Stephen J; Gahl WA; Huizing M; Malicdan MCV; Adams DR; Gochuico BR
Orphanet J Rare Dis; 2019 Feb; 14(1):52. PubMed ID: 30791930
[TBL] [Abstract][Full Text] [Related]
16. OCA5, a novel locus for non-syndromic oculocutaneous albinism, maps to chromosome 4q24.
Kausar T; Bhatti MA; Ali M; Shaikh RS; Ahmed ZM
Clin Genet; 2013 Jul; 84(1):91-3. PubMed ID: 23050561
[No Abstract] [Full Text] [Related]
17. [Oculocutaneous albinism in French overseas territories (Reunion, French Guyana, Martinique) and Mayotte. Study of 21 cases in 16 families].
Aquaron R; Berge-Lefranc JL; Badens C; Roche J; Fite A; Sainte-Marie D; Piquion N; Cartault F
Med Trop (Mars); 2005 Nov; 65(6):584-91. PubMed ID: 16555521
[TBL] [Abstract][Full Text] [Related]
18. [Study of tyrosinase gene mutation in oculocutaneous albinism type 1 patients].
Zheng H; Huang ZG; Wen RQ; Li HY
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2011 Aug; 27(3):329-32. PubMed ID: 22097729
[TBL] [Abstract][Full Text] [Related]
19. Sequence analysis of tyrosinase gene in ocular and oculocutaneous albinism patients: introducing three novel mutations.
Khordadpoor-Deilamani F; Akbari MT; Karimipoor M; Javadi G
Mol Vis; 2015; 21():730-5. PubMed ID: 26167114
[TBL] [Abstract][Full Text] [Related]
20. Mild form of oculocutaneous albinism type 1: phenotypic analysis of compound heterozygous patients with the R402Q variant of the
Monfermé S; Lasseaux E; Duncombe-Poulet C; Hamel C; Defoort-Dhellemmes S; Drumare I; Zanlonghi X; Dollfus H; Perdomo Y; Bonneau D; Korobelnik JF; Plaisant C; Michaud V; Pennamen P; Rooryck-Thambo C; Morice-Picard F; Paya C; Arveiler B
Br J Ophthalmol; 2019 Sep; 103(9):1239-1247. PubMed ID: 30472657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
